LEARNING OBJECTIVES:
• Discuss strategies for how healthcare organizations are coping with and overcoming drug shortages
• Understand and recognize challenges within the healthcare industry related to drug shortages and potential sourcing solutions to support a resilient supply chain
• Gain knowledge on how to collaborate within the healthcare community to address drug shortages
• Describe supply chain challenges and successes during the COVID-19 pandemic learning from various industry stakeholders
CO-SPEAKERS:
STACY LAUDERDALE
Stacy Lauderdale is the Senior Director of Drug Information at Vizient. During her 14 years with the Vizient family of companies, Stacy has been responsible for the oversight and development of clinical pharmacy resources including formulary resources, pharmacy communications, expert panels, and education. In 2018, in collaboration with the Vizient Pharmacy Clinical Council, she created a member drug shortage group that prepares drug shortage mitigation strategies with a focus on developing strategies for essential medications. Prior to joining Vizient, she worked for several years in academia and provided drug information services to multiple health systems.
DOUG KUCERA
Doug Kucera is Associate Vice-President, Contract Services at Vizient. During his 14 years with the organization, Doug has managed and led strategic sourcing for several pharmacy product and service categories. Most recently, Doug led the formation of Novaplus Enhanced Supply, in support of Vizient’s mission to end drug shortages. Doug has served on the Vizient Drug Shortages Task Force Executive Committee—and is a participant in the End Drug Shortages Alliance. Prior to joining Vizient, Doug worked in strategic research, pricing, & compliance positions in other industries. Doug has BS and BA degrees in international business and Spanish from the University of Nebraska-Lincoln.
Latest Videos
View all Videos
Anthony Curraro, the Director of Pharmacy Operations at Mount Sinai in New York City, shares his insights on the challenges and goals of the organization. He emphasizes the importance of addressing drug shortages and the need for effective plans and protocols to ensure drug availability. With a focus on the biosimilar landscape to reduce costs, Anthony also highlights the significance of mentorship and leadership development within the health system. As he manages direct contracting across multiple care sites, he is committed to improving compound production through automation projects.
Charlotte Dixon, the Chief Strategy Pharmacy Contracting Officer at Ochsner Health System, leads a centralized purchasing team in New Orleans with plans to expand into North Louisiana. Her focus is on modeling cost savings and building initiatives while addressing critical drug shortages, particularly in chemotherapy and IV fluids. Charlotte emphasizes the importance of mentorship, transparency, and strategic partnerships to foster growth among pharmacy leaders.
Michele Shaeffer, Associate Director of Pharmacy Operations at Jefferson Abington Hospital, shares insights on optimizing pharmacy workflows amidst staffing and medication shortages, highlighting automation and ADC cabinets for improved efficiency and safety. She also emphasizes cross-department collaboration and staff training as essential for addressing these challenges. Looking ahead, she sees innovations in legislation, technology, and industry-wide collaboration as key drivers of progress in tackling systemic issues like drug shortages.